Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan
· Delayed Price · Currency is TWD 70.50
+0.50 (0.71%)
At close: Dec 5, 2025
Shine-On BioMedical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 20.63 | 44.66 | 102.02 | 373.16 | 824.98 |
| Short-Term Investments | 936 | 999 | 1,035 | 793 | 81 |
| Cash & Short-Term Investments | 956.63 | 1,044 | 1,137 | 1,166 | 905.98 |
| Cash Growth | -12.42% | -8.21% | -2.50% | 28.72% | - |
| Accounts Receivable | - | - | 10 | - | - |
| Other Receivables | 1.08 | 2.31 | 2.06 | 1.18 | - |
| Receivables | 1.08 | 2.31 | 12.06 | 1.18 | - |
| Prepaid Expenses | 15.47 | 6.34 | 4.57 | 1.49 | 0.32 |
| Other Current Assets | 0.05 | - | - | 0 | - |
| Total Current Assets | 973.23 | 1,052 | 1,154 | 1,169 | 906.31 |
| Property, Plant & Equipment | 2.11 | 2.83 | 1.54 | 3.03 | 3.99 |
| Other Intangible Assets | 4.36 | 3.62 | 3.59 | 3.36 | 1.24 |
| Long-Term Deferred Tax Assets | - | - | 0.04 | 2.27 | - |
| Other Long-Term Assets | 2.39 | 1.03 | 0.89 | 0.28 | 0.28 |
| Total Assets | 982.08 | 1,060 | 1,160 | 1,178 | 911.82 |
| Accounts Payable | - | - | 2.86 | - | 0.19 |
| Accrued Expenses | 1.24 | 0.26 | 0.57 | 0.01 | 1 |
| Current Portion of Leases | 1.3 | 1.24 | 0.54 | 0.54 | 0.97 |
| Other Current Liabilities | 5.92 | 39.09 | 19.29 | 2.61 | 0.59 |
| Total Current Liabilities | 8.46 | 40.6 | 23.26 | 3.17 | 2.74 |
| Long-Term Leases | 0.68 | 1.36 | - | 0.98 | 1.52 |
| Long-Term Deferred Tax Liabilities | 0.01 | 0.26 | - | - | - |
| Total Liabilities | 9.15 | 42.21 | 23.26 | 4.14 | 4.26 |
| Common Stock | 498 | 498 | 498 | 498 | 430 |
| Additional Paid-In Capital | 703.6 | 703.6 | 703.6 | 703.6 | 486 |
| Retained Earnings | -228.67 | -184.03 | -65.14 | -27.98 | -8.43 |
| Shareholders' Equity | 972.93 | 1,018 | 1,136 | 1,174 | 907.57 |
| Total Liabilities & Equity | 982.08 | 1,060 | 1,160 | 1,178 | 911.82 |
| Total Debt | 1.98 | 2.6 | 0.54 | 1.52 | 2.48 |
| Net Cash (Debt) | 954.65 | 1,041 | 1,136 | 1,165 | 903.5 |
| Net Cash Growth | -12.35% | -8.40% | -2.42% | 28.90% | - |
| Net Cash Per Share | 19.17 | 20.90 | 22.82 | 25.65 | 48.91 |
| Filing Date Shares Outstanding | 49.8 | 49.8 | 49.8 | 49.8 | 49.8 |
| Total Common Shares Outstanding | 49.8 | 49.8 | 49.8 | 49.8 | 49.8 |
| Working Capital | 964.77 | 1,012 | 1,130 | 1,166 | 903.57 |
| Book Value Per Share | 19.54 | 20.43 | 22.82 | 23.57 | 18.22 |
| Tangible Book Value | 968.57 | 1,014 | 1,133 | 1,170 | 906.33 |
| Tangible Book Value Per Share | 19.45 | 20.36 | 22.75 | 23.50 | 18.20 |
| Machinery | 1.26 | 1.23 | 1.86 | 1.79 | 1.31 |
| Leasehold Improvements | 0.02 | 0.02 | 0.37 | 0.37 | 0.37 |
Source: S&P Capital IQ. Standard template. Financial Sources.